title: Mitomycin C directly augments the expression of HLA-DR antigen in a gastric carcinoma cell line.
authors.affiliation: Department of Surgery, Kyushu University, Beppu, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Inoue
authors.forename: M
authors.initials: M
authors.lastname: Adachi
authors.forename: S
authors.initials: S
authors.lastname: Arinaga
authors.forename: H
authors.initials: H
authors.lastname: Ueo
authors.forename: T
authors.initials: T
authors.lastname: Akiyoshi
mesh_terms: D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000951:Antigens, Neoplasm / Q000032:analysis / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D006684:HLA-DR Antigens / Q000032:analysis / Q000187:drug effects*; D006801:Humans; D007150:Immunohistochemistry; D007371:Interferon-gamma / Q000494:pharmacology; D016685:Mitomycin / Q000494:pharmacology*; D013274:Stomach Neoplasms / Q000737:chemistry / Q000188:drug therapy* / Q000276:immunology*; D014407:Tumor Cells, Cultured / Q000187:drug effects
chemical_list: D000276:Adjuvants, Immunologic; D000951:Antigens, Neoplasm; D006684:HLA-DR Antigens; D016685:Mitomycin; D007371:Interferon-gamma